Turn awareness into action this World Amyloidosis Day using our suite of free educational resources, co-developed with leading multidisciplinary clinicians: amyloidosis-center-hub.ime.s…

We'd love to see you at #ESMO26! Come and see us at Booth 1035 to discover our expert-led programs in oncology 🧬

Candidate selection and surgical considerations for presbyopia-correcting intraocular lenses: Start learning in these free, CME-accredited patient case modules, developed by Dr. Rahul Tonk and Dr. Caroline Watson: presbyopia-pc-iol-surgery.im…

Watch these free video interviews and learn how leading amyloidosis centers in Argentina, Brazil and Mexico have strengthened care services, sharing real-world lessons on multidisciplinary collaboration, care pathways and overcoming barriers to care: amyloidosis-center-hub.ime.s…

Ophthalmic surgeons: Mark World Sight Day with this free, CME-accredited video podcast series on presbyopia-correcting intraocular lenses, led by Dr. Jennifer Loh: presbyopia-pc-iol-surgery.im…

Are you up to date with the latest advancements in the management of HER2-positive NSCLC? Gain practical insights on biomarker testing, HER2-targeted therapies, and emerging treatment strategies with this free video podcast series: her2-mutations-nsclc.ime.spr…

Developed by Dr. Amy McMichael and Dr. Arash Mostaghimi, these real-world patient cases provide practical, case-based learning designed to strengthen clinical decision-making and support evidence-based treatment strategies in real-world alopecia areata: ime.springermedicine.com/pro…

In this patient-physician conversation, Dr. Kristen Flint unpicks real-world patient experiences with CGM, from adoption challenges to the importance of shared decision-making, highlighting the need for individualized strategies in diabetes care: diabetes-cgm.ime.springerhea…

Attending IMS 2026 and looking to stay ahead of the discussion on newly diagnosed multiple myeloma (NDMM)? Watch this free, on-demand webcast and discover how BCMA-directed therapies could reshape the frontline treatment paradigm in NDMM: ime.springermedicine.com/lea…

This World Alzheimer's Month, build your own personalized summary of best practices and clinical evidence on the use of biomarkers to support diagnosis, treatment selection and monitoring in Alzheimer’s disease using our free infographic builder: alzheimers-biomarkers-mdt.im…

Mark World Alzheimer’s Month by exploring the latest advances in PET imaging using these free, regionally focused clinical simulations, designed to optimize your selection, interpretation, and reporting of PET biomarkers in practice: navigate-imaging-alzheimers-…

Candidate selection and surgical considerations for presbyopia-correcting intraocular lenses: Start learning in these free, CME-accredited patient case modules, developed by Dr. Rahul Tonk and Dr. Caroline Watson: presbyopia-pc-iol-surgery.im…

Help shape the discussion at #ESCCongress 2026 by sharing your experience of managing patients with heart failure and kidney impairment. Which unmet need in HF with kidney impairment management are you most hopeful new evidence will address?

Unpick regional disparities and patient perspectives on systemic lupus erythematosus in this free, CME-accredited video series, led by Prof. Martin Aringer and international experts in lupus care: sle-guidelines-to-practice.i…

Help shape the discussion at #ESCCongress 2026 by sharing your experience of managing patients with heart failure and kidney impairment. A patient's eGFR dips after starting an SGLT2 inhibitor. What's your first move?

Hear from Dr. Larisa J. Geskin and fellow clinical experts in our free, CME-accredited webcast, where they explore the evolving therapeutic landscape of the tumor microenvironment in mycosis fungoides–type cutaneous T-cell lymphoma: ime.springermedicine.com/lea…

Help shape the discussion at #ESCCongress 2026 by sharing your experience of managing patients with heart failure and kidney impairment. What's the biggest barrier to optimising HF GDMT in patients with kidney impairment?

Looking to refine your decision-making skills in decoding HER2 mutations and overexpression in NSCLC? Explore our free, CME-accredited case scenarios to unpick the latest clinical trial data and emerging treatment regimens for HER2 NSCLC: her2-mutations-nsclc.ime.spr…

Help shape the discussion at #ESCCongress 2026 by sharing your experience of managing patients with heart failure and kidney impairment. Which kidney biomarker most influences your heart failure management decisions?

Help shape the discussion at #ESCCongress 2026 by sharing your experience of managing patients with heart failure and kidney impairment. How often do you test UACR (urine albumin-to-creatinine ratio) in patients with HF?